Australia's EchoIQ jumps on positive study results for heart failure detection system
03/09/2024 02:23
** Shares of EchoIQ EIQ.AX rise as much as 13.3% to
A$0.170, their biggest intraday gain since May 16
** Stock hits its highest level since July 16
** Medical technology co reports positive results from two
clinical studies for its 'Heart Failure AI system' in detecting
new onset heart failure
** Says co's AI solution, without human review, detects 86%
of heart failure cases, compared with 46% in current standard
clinical practice
** About 1.3 mln shares change hands, compared with the
30-day average volume of around 391,000
** Stock down 2.9% YTD, including session's move
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt